Triptolide Improves Early Survival of Mesenchymal Stem Cells Transplanted into Rat Myocardium

Abstract

Objective: To investigate whether triptolide can prolong the survival of rat mesenchymal stem cells (MSCs) transfected with the mouse hyperpolarization-activated cyclic nucleotide-gated channel 4 (mHCN4) gene in the myocardium. Methods: Grafted cell survival was determined using a sex-mismatched cell transplantation model and analysis of Y chromosome-specific Sry gene expression from hearts harvested at different time points after cell transplantation. ELISA and RT-PCR were used to measure protein and mRNA levels, respectively, of nuclear factor (NF)-κB, IL-1ß, IL-6 and TNF-a. Results: Donor cell numbers decreased over time. Pretreatment with triptolide improved graft survival both 24 (29.3 ± 0.9%) and 72 h (17.5 ± 1.2%) after transplantation of MSCs and resulted in a 2.5-fold increase in the total cell number 72 h after cell transplantation. The mRNA expression and protein content of NF-κB, IL-1ß, IL-6 and TNF-a were significantly reduced in the triptolide-treated group compared with the control groups. In addition, triptolide downregulated Bax but upregulated Bcl-2 in the injected region. Conclusions: Transient treatment with triptolide may significantly improve the early survival of MSCs in vivo. The mechanism underlying this effect involves attenuating the inflammatory response via inhibition of the NF-κB signaling pathway.

Association of hemodynamic factors and progressive aortic dilatation following type A aortic dissection surgical repair

“…In contrast, a patient (US#5) with a large primary entry tear had a considerably high pressure difference as flow entering the FL appeared to be unidirectional with no exit to relieve the pressure. As reported in the literature 40 , in the case of blind end of the FL, absence of a distal tear or a side branch to shunt pressure from the FL may result in pressure difference between TL and FL.…”

Mesenchymal stem cells overexpressing adrenomedullin improve heart function through antifibrotic action in rats experiencing heart failure

“…Stem cell transplantation has been extensively investigated as a therapy for heart failure ( 1 , 2 ). Mesenchymal stem cells (MSCs), which have the ability to escape detection by the host immune system upon transplantation and to expand easily, become a promising source of cells for transplantation ( 3 ).…”